Top Key Companies for Prostate-Specific Antigen Testing Market: Xiamen Biotime Biotechnology Co., Ltd., HWTAi,, OptiBio Co., Ltd, Jiangsu MicroDiag Biomedicine Technology Co.,Ltd., Beijing Hotgen Biotechn Co., Ltd, Humasis,AccuquikTMTest Kits, CTK Biotech, Inc., INTEC, XIAMEN BOSON BIOTECH CO.,LTD, AccuBioTech Co, Ltd., Bio-Rad Laboratories, Inc., Accuquik Test Kits, OPKO Health, Inc., bioMérieux SA, Beckman Coulter, Inc., Abbott, Siemens Healthcare, DiaSorin, F.Hoffmann-La Roche Ltd, Mediwatch (LABORIE), BodiTech, Bristol-Myers Squibb Company, GE Healthcare, Endocare, GlaxoSmithKline, Anixa Biosciences, Ortho Clinical, Fujirebio, Pharmacia Delfia.
Global Prostate-Specific Antigen Testing Market Size was estimated at USD 15941.15 million in 2022 and is projected to reach USD 19869.97 million by 2028, exhibiting a CAGR of 3.74% during the forecast period.
Global Prostate-Specific Antigen Testing Market Overview And Scope:
The Global Prostate-Specific Antigen Testing Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Prostate-Specific Antigen Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Prostate-Specific Antigen Testing Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostate-Specific Antigen Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Prostate-Specific Antigen Testing market.
Global Prostate-Specific Antigen Testing Market Segmentation
By Type, Prostate-Specific Antigen Testing market has been segmented into:
Immunoassay
Timely Test Kits
By Application, Prostate-Specific Antigen Testing market has been segmented into:
Hospital
Diagnostic Laboratory
Specialty Clinic
Other
Regional Analysis of Prostate-Specific Antigen Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Prostate-Specific Antigen Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Prostate-Specific Antigen Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Prostate-Specific Antigen Testing market.
Top Key Companies Covered in Prostate-Specific Antigen Testing market are:
Xiamen Biotime Biotechnology Co.
Ltd.
HWTAi
OptiBio Co.
Ltd
Jiangsu MicroDiag Biomedicine Technology Co.
Ltd.
Beijing Hotgen Biotechn Co.
Ltd
Humasis
AccuquikTMTest Kits
CTK Biotech
Inc.
INTEC
XIAMEN BOSON BIOTECH CO.
LTD
AccuBioTech Co
Ltd.
Bio-Rad Laboratories
Inc.
Accuquik Test Kits
OPKO Health
Inc.
bioMérieux SA
Beckman Coulter
Inc.
Abbott
Siemens Healthcare
DiaSorin
F.Hoffmann-La Roche Ltd
Mediwatch (LABORIE)
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
GlaxoSmithKline
Anixa Biosciences
Ortho Clinical
Fujirebio
Pharmacia Delfia
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Prostate-Specific Antigen Testing Market by Type
5.1 Prostate-Specific Antigen Testing Market Overview Snapshot and Growth Engine
5.2 Prostate-Specific Antigen Testing Market Overview
5.3 Immunoassay
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Immunoassay: Geographic Segmentation
5.4 Timely Test Kits
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Timely Test Kits: Geographic Segmentation
Chapter 6: Prostate-Specific Antigen Testing Market by Application
6.1 Prostate-Specific Antigen Testing Market Overview Snapshot and Growth Engine
6.2 Prostate-Specific Antigen Testing Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Diagnostic Laboratory
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostic Laboratory: Geographic Segmentation
6.5 Specialty Clinic
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Specialty Clinic: Geographic Segmentation
6.6 Other
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Prostate-Specific Antigen Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Prostate-Specific Antigen Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Prostate-Specific Antigen Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 XIAMEN BIOTIME BIOTECHNOLOGY CO.
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 LTD.
7.4 HWTAI
7.5
7.6 OPTIBIO CO.
7.7 LTD
7.8 JIANGSU MICRODIAG BIOMEDICINE TECHNOLOGY CO.
7.9 LTD.
7.10 BEIJING HOTGEN BIOTECHN CO.
7.11 LTD
7.12 HUMASIS
7.13 ACCUQUIKTMTEST KITS
7.14 CTK BIOTECH
7.15 INC.
7.16 INTEC
7.17 XIAMEN BOSON BIOTECH CO.
7.18 LTD
7.19 ACCUBIOTECH CO
7.20 LTD.
7.21 BIO-RAD LABORATORIES
7.22 INC.
7.23 ACCUQUIK TEST KITS
7.24 OPKO HEALTH
7.25 INC.
7.26 BIOMÉRIEUX SA
7.27 BECKMAN COULTER
7.28 INC.
7.29 ABBOTT
7.30 SIEMENS HEALTHCARE
7.31 DIASORIN
7.32 F.HOFFMANN-LA ROCHE LTD
7.33 MEDIWATCH (LABORIE)
7.34 BODITECH
7.35 BRISTOL-MYERS SQUIBB COMPANY
7.36 GE HEALTHCARE
7.37 ENDOCARE
7.38 GLAXOSMITHKLINE
7.39 ANIXA BIOSCIENCES
7.40 ORTHO CLINICAL
7.41 FUJIREBIO
7.42 PHARMACIA DELFIA
Chapter 8: Global Prostate-Specific Antigen Testing Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Immunoassay
8.2.2 Timely Test Kits
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Diagnostic Laboratory
8.3.3 Specialty Clinic
8.3.4 Other
Chapter 9: North America Prostate-Specific Antigen Testing Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Immunoassay
9.4.2 Timely Test Kits
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Diagnostic Laboratory
9.5.3 Specialty Clinic
9.5.4 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Prostate-Specific Antigen Testing Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Immunoassay
10.4.2 Timely Test Kits
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Diagnostic Laboratory
10.5.3 Specialty Clinic
10.5.4 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Prostate-Specific Antigen Testing Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Immunoassay
11.4.2 Timely Test Kits
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Diagnostic Laboratory
11.5.3 Specialty Clinic
11.5.4 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Prostate-Specific Antigen Testing Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Immunoassay
12.4.2 Timely Test Kits
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Diagnostic Laboratory
12.5.3 Specialty Clinic
12.5.4 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Prostate-Specific Antigen Testing Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Immunoassay
13.4.2 Timely Test Kits
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Diagnostic Laboratory
13.5.3 Specialty Clinic
13.5.4 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Prostate-Specific Antigen Testing Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Immunoassay
14.4.2 Timely Test Kits
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Diagnostic Laboratory
14.5.3 Specialty Clinic
14.5.4 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Prostate-Specific Antigen Testing Scope:
|
Report Data
|
Prostate-Specific Antigen Testing Market
|
|
Prostate-Specific Antigen Testing Market Size in 2025
|
USD XX million
|
|
Prostate-Specific Antigen Testing CAGR 2025 - 2032
|
XX%
|
|
Prostate-Specific Antigen Testing Base Year
|
2024
|
|
Prostate-Specific Antigen Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Xiamen Biotime Biotechnology Co., Ltd., HWTAi,, OptiBio Co., Ltd, Jiangsu MicroDiag Biomedicine Technology Co.,Ltd., Beijing Hotgen Biotechn Co., Ltd, Humasis,AccuquikTMTest Kits, CTK Biotech, Inc., INTEC, XIAMEN BOSON BIOTECH CO.,LTD, AccuBioTech Co, Ltd., Bio-Rad Laboratories, Inc., Accuquik Test Kits, OPKO Health, Inc., bioMérieux SA, Beckman Coulter, Inc., Abbott, Siemens Healthcare, DiaSorin, F.Hoffmann-La Roche Ltd, Mediwatch (LABORIE), BodiTech, Bristol-Myers Squibb Company, GE Healthcare, Endocare, GlaxoSmithKline, Anixa Biosciences, Ortho Clinical, Fujirebio, Pharmacia Delfia.
|
|
Key Segments
|
By Type
Immunoassay
Timely Test Kits
By Applications
Hospital
Diagnostic Laboratory
Specialty Clinic
Other
|
